Funding Opportunities and Notices

NIBIB is passing along the weekly NIH Guide for Grants and Contracts Table of Contents. Scroll down for information and opportunities that may be of interest. Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts   September 9, 2022 General Notices Notice of NCCIH Technical Assistance Webinar for RFA-AT-23-001 and RFA-AT-23-002 (NOT-AT-22-031) National Center for Complementary and Integrative Health Notice of Increase to NIGMS K99 Support Levels (NOT-GM-22-045) National Institute of General Medical Sciences Notice of Pre-Application Webinar for the Maternal Health Research Centers of Excellence Funding Opportunity Announcements (NOT-HD-22-044) Eunice Kennedy Shriver National Institute of Child Health and Human Development Notice of NIH Participation in the NIH-NSF Ecology and Evolution of Infectious Diseases Program (NOT-TW-22-005) John E. Fogarty International Center National Institute of Allergy and Infectious Diseases National Institute of General Medical Sciences Request for Information (RFI): Seeking Input for the National Cancer Institute (NCI) on Expanding the Development of the Integrated Canine Data Commons (NOT-CA-22-125) National Cancer Institute Request for Information: Future Research Needs and Infrastructure Support for Newborn Screening Research (NOT-HD-22-042) Eunice Kennedy Shriver National Institute of Child Health and Human Development Notice of Changes to Funding Opportunities Notice of Participation of the National Institute on Aging (NIA) in RFA-DA-23-051, "HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional)" (NOT-AG-22-033) National Institute on Aging Notice of Participation of the National Institute on Aging (NIA) in RFA-DA-23-053, "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 - Clinical Trial Optional)" (NOT-AG-22-034) National Institute on Aging Notice of Participation of the National Institute on Aging (NIA) in RFA-DA-23-054, "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 - Clinical Trial Optional)" (NOT-AG-22-035) National Institute on Aging Notice of Participation of the National Institute on Aging (NIA) in RFA-DA-23-049, "HEAL Initiative: Therapeutics Development for Opioid Use Disorder in Patients with Co-occurring Mental Disorders (UG3/UH3 - Clinical Trial Optional)" (NOT-AG-22-036) National Institute on Aging Notice of NCCIH Participation in PAR-22-181, "NIDA, NIMH, NINR, and NINDS Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)" (NOT-AT-22-030) National Center for Complementary and Integrative Health Notice of Change to Award Information for RFA-DK-22-506 and RFA-DK-22-507, Limited Competition for the Continuation of the APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Centers (Collaborative U01 - Clinical Trial Not Allowed) (NOT-DK-22-029) National Institute of Diabetes and Digestive and Kidney Diseases Notice of Additional Receipt Date for RFA-ES-19-011 "Mechanism for Time-Sensitive Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)" (NOT-ES-22-013) National Institute of Environmental Health Sciences Notice of NEI's Participation in NOT-OD-04-047 "High Priority, Short-Term Project Award (R56)" (NOT-EY-22-015) National Eye Institute Notice of Early Termination of NOT-OD-22-031, Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) (NOT-OD-22-209) Office of Research on Women's Health Notices of Special Interest Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) (NOT-OD-22-202) Office of Dietary Supplements National Center for Complementary and Integrative Health National Cancer Institute National Institute of Diabetes and Digestive and Kidney Diseases Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions (NOT-OD-22-203) Office of Behavioral and Social Sciences Research National Center for Complementary and Integrative Health National Cancer Institute National Institute on Aging National Institute on Drug Abuse National Institute of Dental and Craniofacial Research National Institute of Nursing Research Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) (NOT-OD-22-208) Office of Research on Women's Health National Center for Complementary and Integrative Health National Cancer Institute National Eye Institute National Heart, Lung, and Blood Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Diabetes and Digestive and Kidney Diseases National Institute of Environmental Health Sciences National Institute of General Medical Sciences National Institute of Mental Health National Institute of Neurological Disorders and Stroke National Institute of Nursing Research Funding Opportunities Development of Animal Models and Related Materials for HIV/AIDS Research (R24 Clinical Trials Not Allowed) (PAR-22-204) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Application Receipt Date(s): Multiple dates, see announcement. NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R01 Clinical Trial Optional) (PAR-22-230) National Institute of Nursing Research Application Receipt Date(s): Multiple dates, see announcement. NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R21 Clinical Trial Optional) (PAR-22-231) National Institute of Nursing Research Application Receipt Date(s): Multiple dates, see announcement. Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) (PAR-22-242) National Cancer Institute National Eye Institute National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Neurological Disorders and Stroke Application Receipt Date(s): September 07, 2025 Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) (PAR-22-243) National Cancer Institute National Institute of Neurological Disorders and Stroke Application Receipt Date(s): September 07, 2025 NIH Blueprint for Neuroscience Research: Computational Training in Neuroscience and Behavior (T90/R90 - Clinical Trial Not Allowed) (RFA-DA-23-037) National Institute on Drug Abuse National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute of Dental and Craniofacial Research National Institute of Environmental Health Sciences National Institute of Mental Health National Institute of Neurological Disorders and Stroke Office of Behavioral and Social Sciences Research Application Receipt Date(s): November 29, 2022 Elucidation and Validation of the role of Transporters in the Placenta, Lactating Mammary Gland, Developing Gut, and Blood Brain Barrier (UC2 Clinical Trial Not Allowed) (RFA-HD-23-003) Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse Office of Dietary Supplements Application Receipt Date(s): November 30, 2022 Pediatric Clinical Pharmacology Research Career Development Award (K12 Clinical Trial Not Allowed) (RFA-HD-23-023) Eunice Kennedy Shriver National Institute of Child Health and Human Development Application Receipt Date(s): December 06, 2022 Multi-Omics for Health and Disease - Disease Study Sites (U01 Clinical Trial Optional) (RFA-HG-22-008) National Human Genome Research Institute National Cancer Institute National Institute of Environmental Health Sciences Application Receipt Date(s): November 18, 2022 Multi-Omics for Health and Disease - 'Omics Production Centers (U01 Clinical Trial Not Allowed) (RFA-HG-22-009) National Human Genome Research Institute National Cancer Institute National Institute of Environmental Health Sciences Application Receipt Date(s): November 18, 2022 Multi-Omics for Health and Disease - Data Analysis and Coordination Center (U01 Clinical Trial Not Allowed) (RFA-HG-22-010) National Human Genome Research Institute National Cancer Institute National Institute of Environmental Health Sciences Application Receipt Date(s): November 18, 2022 Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed) (RFA-OD-22-013) Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs Application Receipt Date(s): Multiple dates, see announcement. NIH Funding Opportunities now available in RSS (Really Simple News Syndication) format - click here for details. To UnSubscribe to the NIH Guide Weekly TOC LISTSERV, follow the instructions here. This weekly list can be found here. To join or leave the NIBIB Listserv, please visit this webpage and complete the online form. You can also change your options for the Listserv at this site.

HOME  |  DISCLAIMER  |  POLICIES  |  ACCESSIBILITY  |  FOIA  |  NEWS  |  CONTACT US

SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

---

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud, on behalf of: National Institute for Biomedical Imaging and Bioengineering · 9000 Rockville Pike, Building 31, Room 1C14, Bethesda, MD 20892